Treatment of functioning insulinoma using endoscopic ultrasound-guided radiofrequency ablation.

85-year-old patient who underwent endoscopic ultrasound (EUS)-guided radiofrequency ablation for a functioning pancreatic insulinoma and was previously treated with acenocoumarol due to a high thrombotic risk. Acenocoumarol was discontinued three days prior to the procedure and replaced with enoxaparin at 40 mg daily, with the basal anticoagulant therapy being restarted 24 hours after the procedure. Ten days later, the patient was diagnosed with an acute hematoma in the tail of the pancreas and gastric body, which led to clinical signs of hypotension and acute anemia, requiring the discontinuation of anticoagulation once again.

Valproic Acid and Lamotrigine Differentially Modulate the Telomere Length in Epilepsy Patients.

: Antiseizure drugs (ASDs) are the primary therapy for epilepsy, and the choice varies according to seizure type. Epilepsy patients experience chronic mitochondrial oxidative stress and increased levels of pro-inflammatory mediators, recognizable hallmarks of biological aging; however, few studies have explored aging markers in epilepsy. Herein, we addressed for the first time the impact of ASDs on molecular aging by measuring the telomere length (TL) and mtDNA copy number (mtDNA-CN).

Enhancing Se(IV) bioremediation efficiency via immobilization of filamentous fungi and yeasts in eco-friendly alginate bead hydrogels.

The immobilization of microorganisms in polymeric hydrogel has gained attention as a potential method for applications in various fields, offering several advantages over traditional cell free-living technologies. The present study aims to compare the efficiency of selenium (Se) bioremediation and biorecovery by two different fungal types, both in their free and immobilized forms using alginate hydrogels. Our results demonstrated an improvement in the amount of Se(IV) removed from the hydrogels of Aspergillus ochraceus (∼97%) and Rhodotorula mucilaginosa (∼43%) compared to that of the planktonic cultures (∼57% and ∼9-17%).

Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes.

Background: Metformin is the first-line antidiabetic therapy for type 2 diabetes in Mexico, despite recent recommendations highlighting alternatives like GLP-1 receptor agonists for individuals with obesity. Metformin elimination is reliant on liver and kidney function, and variants in transport proteins such as Multidrug and Toxin Extrusion Protein 1 (MATE1), MATE2, and Organic Cation Transporter 2 (OCT2) can influence its pharmacokinetics. Understanding these variants' frequencies in the Mexican population is crucial for tailoring personalized treatment strategies.